Nov 23, 2020 - The peculiar rise of protein inflation

From the Editor's Desk

What Went Wrong With IBM's Watson

The A.I. project was supposed to change the state of cancer treatment. Here's what happened instead.

What if artificial intelligence can't cure cancer after all? That's the message of a big Wall Street Journal post-mortem on Watson, the IBM project that was supposed to turn IBM's computing prowess into a scalable program that could deliver state-of-the-art personalized cancer treatment protocols to millions of patients around the world.

Watson in general, and its oncology application in particular, has been receiving a lot of skeptical coverage of late; STAT published a major investigation last year, reporting that Watson was nowhere near being able to live up to IBM's promises. After that article came out, the IBM hype machine started toning things down a bit. But while a lot of the problems with Watson are medical or technical, they're deeply financial, too.

Continued here

TradeBriefs: What's important, not just what's popular!

Advertisers of the day

Emeritus: PG Diploma in Innovation & Design Thinking online program | Accepting applications

Emeritus : PG Diploma in Digital Marketing Strategies in collaboration with Columbia Business School Executive Education | Apply

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.